Share:
Peer-Reviewed Publication
Sleep Breath2026;30(2)April 24, 2026Journal Article

Obstructive sleep apnea, positive airway pressure therapy, and COVID-19 outcomes.

Matthew Klimper1, Jiaxiao Shi2, Adam V Benjafield3, Kate V Cole3, Aiyu Chen2, Joanie Chung2, Jessica Arguelles1, Nathanael H Hwang1, Kendra A Becker1, Joseph B Kim1, Rosa R Woodrum1, Cecilia Portugal2, Olivia H Hwang4, Prasanth Manthena1, Dennis Hwang5
1Sleep Medicine, Kaiser Permanente Southern California, Southern California, USA.
2Department of Research and Evaluation, Kaiser Permanente Southern California, Southern California, USA.
3ResMed Science Center, ResMed Corp, San Diego, USA.
4Scaled Insights, London, England.
5Sleep Medicine, Kaiser Permanente Southern California, Southern California, USA. Dennis.X.Hwang@kp.org.

Abstract

PURPOSE: To quantify the association between obstructive sleep apnea (OSA) and COVID-19 outcomes and test whether adherence to positive airway pressure (PAP) therapy modifies this relationship. METHODS: This retrospective cohort study compared groups with and without OSA, stratified by degrees of PAP adherence (February 1, 2020 to July 31, 2020) from an integrated healthcare system (Kaiser Permane…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.